TUR01

Turgut İlaçları A.Ş. · Phase 1 active Biologic

At a glance

Generic name	TUR01
Also known as	Adalimumab-Turgut
Sponsor	Turgut İlaçları A.Ş.
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Comparative Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of Adalimumab in Healthy Subjects (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

TUR01 CI brief — competitive landscape report
TUR01 updates RSS · CI watch RSS
Turgut İlaçları A.Ş. portfolio CI